| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.457 | 11.996 | 6.533 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 1.648 | 12.116 | 6.555 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 4.276 | 15.055 | 15.774 | 253 | 81 | 117 | 116 | 0 |
| Gross Profit/Loss - EUR | - | - | -2.628 | -2.939 | -9.220 | -253 | -81 | -117 | -116 | 0 |
| Net Profit/Loss - EUR | - | - | -2.645 | -3.135 | -9.416 | -253 | -81 | -117 | -116 | 0 |
| Employees | - | - | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio-Ideal Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 125 | 945 | 926 | 909 | 889 | 891 | 889 | 115 |
| Current Assets | - | - | 22.494 | 17.931 | 14.880 | 14.439 | 14.078 | 14.026 | 13.983 | 13.458 |
| Inventories | - | - | 17.738 | 13.079 | 7.869 | 7.720 | 7.549 | 7.572 | 7.549 | 7.507 |
| Receivables | - | - | 1.317 | 4.189 | 5.587 | 5.527 | 5.420 | 5.459 | 5.443 | 4.965 |
| Cash | - | - | 3.440 | 663 | 1.424 | 1.191 | 1.109 | 994 | 991 | 986 |
| Shareholders Funds | - | - | -2.601 | -5.688 | -14.995 | -14.964 | -14.713 | -14.875 | -14.830 | -14.747 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 25.220 | 24.564 | 30.801 | 30.311 | 29.680 | 29.792 | 29.702 | 28.319 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bio-Ideal Srl